Both in Pharmaceuticals
Rafael Holdings vs Rein Therapeutics
Over the past year RFL returned −19.5% and RNTX returned −53.6%; their daily moves had a correlation of 0.09.
RFL −19.5% RNTX −53.6%Growth of $1, one year, split-adjusted
| Metric | RFL | RNTX |
|---|---|---|
| Price | $1.07 | $0.6587 |
| Market cap | $55.8M | $56.8M |
| Today | −0.93% | −1.32% |
| 1 month | −28.2% | −20.2% |
| 6 months | −14.4% | −43.7% |
| Year to date | −9.3% | −43.2% |
| 1 year | −20.7% | −62.4% |
| Revenue growth (YoY) | −30.3% | — |
| Gross margin | 94.7% | — |
| Net margin | −3760.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 63.9× | — |
| Net cash | $21.5M | $40.6M |
| Dividend yield | — | — |
| Volatility (60d) | 115.0% | 95.8% |
| Short % of float | 1.0% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).